Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome. - Wikidata - wikimedia - TriplyDB

Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome.

Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome.

http://www.wikidata.org/entity/Q37108328

about

Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome.Infectious complications of rituximab therapy in renal disease.

P2860

Q38597096-045D9A2D-3387-4C79-A36C-B33245AFFF82 Q40065728-7057AF9D-983C-4786-B5A0-7B961B667766

P2860

Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome.

http://www.wikidata.org/entity/Q37108328

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Single dose of rituximab in ch ...... mal change nephrotic syndrome.

@en

Single dose of rituximab in ch ...... mal change nephrotic syndrome.

@nl

type

label

Single dose of rituximab in ch ...... mal change nephrotic syndrome.

@en

Single dose of rituximab in ch ...... mal change nephrotic syndrome.

@nl

prefLabel

Single dose of rituximab in ch ...... mal change nephrotic syndrome.

@en

Single dose of rituximab in ch ...... mal change nephrotic syndrome.

@nl

P1433

Q37108328-DE3A571E-2F4B-46AC-B6B0-A0FE4AFFACD0

P1476

Q37108328-047F7B77-E6BB-4D20-8C04-690A84FCA8CF

P2093

Q37108328-161ED129-1A7A-48EF-8430-3A5F544A959C

Q37108328-199F67D1-5FF7-4074-8761-C70C2C1D919C

Q37108328-6632348C-6F26-4EB6-B880-FADADCD5CC10

Q37108328-70A83CFD-4477-4B70-9AEF-81775DBCCD74

Q37108328-A70B5058-1E13-4FF8-957E-D8979EF12A31

Q37108328-D2334510-A891-4BDA-9247-BEFACD980A4E

Q37108328-E0843EE6-B849-47E9-98F9-0AE819BB3BB0

Q37108328-E452FFFC-5E0C-45B6-B136-55200CBF602C

Q37108328-EC912963-0B87-4BF2-AB80-357DED6BE87C

P2860

Q37108328-10998DCA-26A5-4B35-97C4-9917B5064E8D

Q37108328-152A7DAF-4DD9-4762-945E-B4FB8F411790

Q37108328-175C94B9-311F-4F98-A1CC-A13DAAC58445

Q37108328-18A791FD-F999-4EBD-9C00-378426A5E7CC

Q37108328-4C09F416-46AC-47C4-A99F-5BB5CB46E373

Q37108328-5680D741-882C-47DC-87DD-408B06680E07

Q37108328-618DB6E7-A27F-426A-909D-B1E02D36F4D0

Q37108328-76404FE8-C086-4EC5-8B6A-8930A238FA33

Q37108328-81458374-0FCA-4310-915C-CD512E7128FB

Q37108328-B58AB8A5-6C06-44A3-B13A-D53F80E1B795

P304

Q37108328-C038BB2B-DE73-46DF-A64B-91AE76A10769

P31

Q37108328-5804CE04-2F2A-446C-AA19-E4160F92ACB7

P356

Q37108328-70F28DC9-838A-45DF-8B91-E8D735BE2608

P433

Q37108328-B8CEF7DA-3340-4894-95DA-0E1A4F82E4AC

P478

Q37108328-2E0C6130-8BA6-4D7D-8A43-7AEFB00030AB

P577

Q37108328-868F7D84-95FB-4DC0-A823-B6ACEA82283B

P698

Q37108328-31024864-2004-4827-9AEB-F734CBAD807F

P932

Q37108328-635310C8-401E-4707-9F9D-10F066F6FEB9

P356

P1433

Biomedical Reports

P1476

Single dose of rituximab in ch ...... mal change nephrotic syndrome.

@en

P2093

Guang-Hua Zhu

http://www.w3.org/2001/XMLSchema#string

Gui-Mei Guo

http://www.w3.org/2001/XMLSchema#string

Ping Wang

http://www.w3.org/2001/XMLSchema#string

Sheng Hao

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Wen-Yan Huang

http://www.w3.org/2001/XMLSchema#string

Xiao-Ling Niu

http://www.w3.org/2001/XMLSchema#string

Xin-Yu Kuang

http://www.w3.org/2001/XMLSchema#string

Ying Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Non-corticosteroid treatment for nephrotic syndrome in children

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome

Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai.

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.

Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.

Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.

P304

237-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2016.711

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27446549

http://www.w3.org/2001/XMLSchema#string

P932

4950748

http://www.w3.org/2001/XMLSchema#string